Michael Exton's most recent trade in Lexicon Pharmaceuticals Inc was a trade of 2,264,690 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lexicon Pharmaceuticals Inc | Michael Exton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 2,264,690 | 2,264,690 | - | - | Stock Option (Right to Buy) | |
| Lexicon Pharmaceuticals Inc | Michael Exton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 1,509,790 | 1,509,790 | - | - | Restricted Stock Units | |
| Lexicon Pharmaceuticals Inc | Michael Exton | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 1,675,000 | 1,675,000 | - | - | Stock Option (Right to Buy) |